Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector.

David J LeeNagalingeswaran KumarasamyStephen C ReschGomathi N Sivaramakrishnan Kenneth H Mayer Srikanth Tripathy A David Paltiel Kenneth A Freedberg Krishna P Reddy

Published in: PloS one (2019)

Used at the point-of-care in India, Truenat for TB diagnosis should improve linkage-to-care, increase life expectancy, and be cost-effective compared with smear microscopy or Xpert.

Keyphrases

healthcare
mycobacterium tuberculosis
pulmonary tuberculosis
high throughput
palliative care
single molecule
mental health
quality improvement
optical coherence tomography
high speed
gene expression
pain management
adverse drug
label free
human immunodeficiency virus
high density
men who have sex with men